598 related articles for article (PubMed ID: 12036951)
21. Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells.
Jaiswal AS; Marlow BP; Gupta N; Narayan S
Oncogene; 2002 Dec; 21(55):8414-27. PubMed ID: 12466962
[TBL] [Abstract][Full Text] [Related]
22. Infrequent somatic mutations of the ICAT gene in various human cancers with frequent 1p-LOH and/or abnormal nuclear accumulation of beta-catenin.
Imai M; Nakamura T; Akiyama T; Horii A
Oncol Rep; 2004 Nov; 12(5):1099-103. PubMed ID: 15492799
[TBL] [Abstract][Full Text] [Related]
23. Germline APC mutation on the beta-catenin binding site is associated with a decreased apoptotic level in colorectal adenomas.
Venesio T; Balsamo A; Scordamaglia A; Bertolaso M; Arrigoni A; Sprujevnik T; Rossini FP; Risio M
Mod Pathol; 2003 Jan; 16(1):57-65. PubMed ID: 12527714
[TBL] [Abstract][Full Text] [Related]
24. Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer.
Renard CA; Labalette C; Armengol C; Cougot D; Wei Y; Cairo S; Pineau P; Neuveut C; de Reyniès A; Dejean A; Perret C; Buendia MA
Cancer Res; 2007 Feb; 67(3):901-10. PubMed ID: 17283120
[TBL] [Abstract][Full Text] [Related]
25. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
[TBL] [Abstract][Full Text] [Related]
26. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells.
Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD
BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613
[TBL] [Abstract][Full Text] [Related]
27. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.
Wu R; Zhai Y; Fearon ER; Cho KR
Cancer Res; 2001 Nov; 61(22):8247-55. PubMed ID: 11719457
[TBL] [Abstract][Full Text] [Related]
28. [Familial adenomatous polyposis syndrome (FAP): pathogenesis and molecular mechanisms].
Friedrich A; Kullmann F
Med Klin (Munich); 2003 Dec; 98(12):776-82. PubMed ID: 14685680
[TBL] [Abstract][Full Text] [Related]
29. Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC.
Reifenberger J; Knobbe CB; Wolter M; Blaschke B; Schulte KW; Pietsch T; Ruzicka T; Reifenberger G
Int J Cancer; 2002 Aug; 100(5):549-56. PubMed ID: 12124804
[TBL] [Abstract][Full Text] [Related]
30. Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer.
Miyaki M; Iijima T; Kimura J; Yasuno M; Mori T; Hayashi Y; Koike M; Shitara N; Iwama T; Kuroki T
Cancer Res; 1999 Sep; 59(18):4506-9. PubMed ID: 10493496
[TBL] [Abstract][Full Text] [Related]
31. Wnt signaling inside the nucleus.
Shitashige M; Hirohashi S; Yamada T
Cancer Sci; 2008 Apr; 99(4):631-7. PubMed ID: 18177486
[TBL] [Abstract][Full Text] [Related]
32. Up-regulation of the ectodermal-neural cortex 1 (ENC1) gene, a downstream target of the beta-catenin/T-cell factor complex, in colorectal carcinomas.
Fujita M; Furukawa Y; Tsunoda T; Tanaka T; Ogawa M; Nakamura Y
Cancer Res; 2001 Nov; 61(21):7722-6. PubMed ID: 11691783
[TBL] [Abstract][Full Text] [Related]
33. [The role of APC in colonic cancerogenesis: zeroing in on Myc].
Jeanteur P
Bull Cancer; 1998 Nov; 85(11):925-8. PubMed ID: 9951419
[TBL] [Abstract][Full Text] [Related]
34. Genetic and epigenetic alterations of the APC gene in malignant melanoma.
Worm J; Christensen C; Grønbaek K; Tulchinsky E; Guldberg P
Oncogene; 2004 Jul; 23(30):5215-26. PubMed ID: 15133491
[TBL] [Abstract][Full Text] [Related]
35. [From gene to disease; the APC gene and familial adenomatous polyposis coli].
van der Luijt RB; Tops CM; Vasen HF
Ned Tijdschr Geneeskd; 2000 Oct; 144(42):2007-9. PubMed ID: 11072519
[TBL] [Abstract][Full Text] [Related]
36. Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis.
Devereux TR; Anna CH; Foley JF; White CM; Sills RC; Barrett JC
Oncogene; 1999 Aug; 18(33):4726-33. PubMed ID: 10467420
[TBL] [Abstract][Full Text] [Related]
37. Beta-catenin expression and allelic loss at APC in sporadic colorectal carcinogenesis.
Hao X; Frayling IM; Willcocks TC; Han W; Tomlinson IP; Pignatelli MN; Pretlow TP; Talbot IC
Virchows Arch; 2002 Apr; 440(4):362-6. PubMed ID: 11956815
[TBL] [Abstract][Full Text] [Related]
38. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis.
Yamada T; Takaoka AS; Naishiro Y; Hayashi R; Maruyama K; Maesawa C; Ochiai A; Hirohashi S
Cancer Res; 2000 Sep; 60(17):4761-6. PubMed ID: 10987283
[TBL] [Abstract][Full Text] [Related]
39. Restoration of epithelial cell polarity in a colorectal cancer cell line by suppression of beta-catenin/T-cell factor 4-mediated gene transactivation.
Naishiro Y; Yamada T; Takaoka AS; Hayashi R; Hasegawa F; Imai K; Hirohashi S
Cancer Res; 2001 Mar; 61(6):2751-8. PubMed ID: 11289158
[TBL] [Abstract][Full Text] [Related]
40. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade.
Calvisi DF; Factor VM; Loi R; Thorgeirsson SS
Cancer Res; 2001 Mar; 61(5):2085-91. PubMed ID: 11280770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]